{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T07:17:56Z","timestamp":1785827876753,"version":"3.56.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T00:00:00Z","timestamp":1574812800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Western Swedish region"},{"name":"Medical Research Council","award":["MR\/N026004\/1"],"award-info":[{"award-number":["MR\/N026004\/1"]}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["202903\/Z\/16\/Z"],"award-info":[{"award-number":["202903\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["acta neuropathol commun"],"published-print":{"date-parts":[[2019,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Swedish type Hereditary Diffuse Leukoencephalopathy with Spheroids (HDLS-S) is a severe adult-onset leukoencephalopathy with the histopathological hallmark of neuraxonal degeneration with spheroids, described in a large family with a dominant inheritance pattern. The initial stage of the disease is dominated by frontal lobe symptoms that develop into a rapidly advancing encephalopathy with pyramidal, deep sensory, extrapyramidal and optic tract symptoms. Median survival is less than 10\u2009years. Recently, pathogenic mutations in <jats:italic>CSF1R<\/jats:italic> were reported in a clinically and histologically similar leukoencephalopathy segregating in several families. Still, the cause of HDLS-S remained elusive since its initial description in 1984, with no <jats:italic>CSF1R<\/jats:italic> mutations identified in the family. Here we update the original findings associated with HDLS-S after a systematic and recent assessment of several family members. We also report the results from exome sequencing analyses indicating the p.Cys152Phe variant in the alanyl tRNA synthetase <jats:italic>(AARS)<\/jats:italic> gene as the probable cause of this disease. The variant affects an amino acid located in the aminoacylation domain of the protein and does not cause differences in splicing or expression in the brain. Brain pathology in one case after 10\u2009years of disease duration showed the end stage of the disease to be characterized by widespread liquefaction of the white matter leaving only some macrophages and glial cells behind the centrifugally progressing front. These results point to <jats:italic>AARS<\/jats:italic> as a candidate gene for rapidly progressing adult-onset CSF1R-negative leukoencephalopathies.<\/jats:p>","DOI":"10.1186\/s40478-019-0843-y","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T06:02:43Z","timestamp":1574834563000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["An AARS variant as the likely cause of Swedish type hereditary diffuse leukoencephalopathy with spheroids"],"prefix":"10.1186","volume":"7","author":[{"given":"Christina","family":"Sundal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Carmona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Yhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Odd","family":"Almstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Ljungberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carola","family":"Hedberg-Oldfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c5sa","family":"Fred","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Br\u00e1s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Oldfors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluf","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5879-3486","authenticated-orcid":false,"given":"Rita","family":"Guerreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,27]]},"reference":[{"key":"843_CR1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.jocn.2017.10.060","volume":"48","author":"SJ Adams","year":"2018","unstructured":"Adams SJ, Kirk A, Auer RN (2018) Adult-onset leukoencephalopathy with axonal spheroids and pigmented glia (ALSP): integrating the literature on hereditary diffuse leukoencephalopathy with spheroids (HDLS) and pigmentary orthochromatic leukodystrophy (POLD). J Clin Neurosci 48:42\u201349","journal-title":"J Clin Neurosci"},{"issue":"4","key":"843_CR2","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nmeth0410-248","volume":"7","author":"IA Adzhubei","year":"2010","unstructured":"Adzhubei IA et al (2010) A method and server for predicting damaging missense mutations. Nat Methods 7(4):248\u2013249","journal-title":"Nat Methods"},{"issue":"11","key":"843_CR3","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1038\/ejhg.2017.130","volume":"25","author":"A Ameur","year":"2017","unstructured":"Ameur A et al (2017) SweGen: a whole-genome data resource of genetic variability in a cross-section of the Swedish population. Eur J Hum Genet 25(11):1253\u20131260","journal-title":"Eur J Hum Genet"},{"key":"843_CR4","first-page":"1","volume":"314","author":"R Axelsson","year":"1984","unstructured":"Axelsson R et al (1984) Hereditary diffuse leucoencephalopathy with spheroids. Acta Psychiatr Scand Suppl 314:1\u201365","journal-title":"Acta Psychiatr Scand Suppl"},{"issue":"8","key":"843_CR5","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1007\/s00415-015-7778-4","volume":"262","author":"B Bansagi","year":"2015","unstructured":"Bansagi B et al (2015) Genotype\/phenotype correlations in AARS-related neuropathy in a cohort of patients from the United Kingdom and Ireland. J Neurol 262(8):1899\u20131908","journal-title":"J Neurol"},{"issue":"3","key":"843_CR6","doi-asserted-by":"publisher","first-page":"420","DOI":"10.3988\/jcn.2018.14.3.420","volume":"14","author":"G Carle","year":"2018","unstructured":"Carle G et al (2018) Alanyl-tRNA Synthetase 2-related dementia with selective bilateral frontal cystic Leukoencephalopathy. J Clin Neurol 14(3):420\u2013422","journal-title":"J Clin Neurol"},{"issue":"23","key":"843_CR7","doi-asserted-by":"publisher","first-page":"2063","DOI":"10.1212\/WNL.0000000000000497","volume":"82","author":"C Dallabona","year":"2014","unstructured":"Dallabona C et al (2014) Novel (ovario) leukodystrophy related to AARS2 mutations. Neurology 82(23):2063\u20132071","journal-title":"Neurology"},{"issue":"5","key":"843_CR8","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/ng.806","volume":"43","author":"MA DePristo","year":"2011","unstructured":"DePristo MA et al (2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43(5):491\u2013498","journal-title":"Nat Genet"},{"issue":"7","key":"843_CR9","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1001\/jamaneurol.2013.698","volume":"70","author":"R Guerreiro","year":"2013","unstructured":"Guerreiro R et al (2013) Genetic analysis of inherited leukodystrophies: genotype-phenotype correlations in the CSF1R gene. JAMA Neurol 70(7):875\u2013882","journal-title":"JAMA Neurol"},{"issue":"5941","key":"843_CR10","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1126\/science.1174343","volume":"325","author":"M Guo","year":"2009","unstructured":"Guo M et al (2009) The C-Ala domain brings together editing and aminoacylation functions on one tRNA. Science 325(5941):744\u2013747","journal-title":"Science"},{"issue":"S43","key":"843_CR11","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1600-0404.1970.tb02161.x","volume":"46","author":"HP Hakola","year":"1970","unstructured":"Hakola HP, Jarvi OH, Sourander P (1970) Osteodysplasia polycystica hereditaria combined with sclerosing leucoencephalopathy, a new entity of the dementia praesenilis group. Acta Neurol Scand 46(S43):79\u201380","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"843_CR12","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","volume":"46","author":"M Kircher","year":"2014","unstructured":"Kircher M et al (2014) A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 46(3):310\u2013315","journal-title":"Nat Genet"},{"issue":"2","key":"843_CR13","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/nrneurol.2017.175","volume":"14","author":"W Kohler","year":"2018","unstructured":"Kohler W, Curiel J, Vanderver A (2018) Adulthood leukodystrophies. Nat Rev Neurol 14(2):94\u2013105","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"843_CR14","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/ene.13125","volume":"24","author":"T Konno","year":"2017","unstructured":"Konno T et al (2017) Clinical and genetic characterization of adult-onset leukoencephalopathy with axonal spheroids and pigmented glia associated with CSF1R mutation. Eur J Neurol 24(1):37\u201345","journal-title":"Eur J Neurol"},{"issue":"2","key":"843_CR15","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1212\/NXG.0000000000000135","volume":"3","author":"R Lakshmanan","year":"2017","unstructured":"Lakshmanan R et al (2017) Redefining the phenotype of ALSP and AARS2 mutation-related leukodystrophy. Neurol Genet 3(2):e135","journal-title":"Neurol Genet"},{"issue":"1","key":"843_CR16","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ajhg.2009.12.005","volume":"86","author":"P Latour","year":"2010","unstructured":"Latour P et al (2010) A major determinant for binding and aminoacylation of tRNA (Ala) in cytoplasmic Alanyl-tRNA synthetase is mutated in dominant axonal Charcot-Marie-tooth disease. Am J Hum Genet 86(1):77\u201382","journal-title":"Am J Hum Genet"},{"issue":"7107","key":"843_CR17","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/nature05096","volume":"443","author":"JW Lee","year":"2006","unstructured":"Lee JW et al (2006) Editing-defective tRNA synthetase causes protein misfolding and neurodegeneration. Nature 443(7107):50\u201355","journal-title":"Nature"},{"issue":"5","key":"843_CR18","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1093\/bioinformatics\/btp698","volume":"26","author":"H Li","year":"2010","unstructured":"Li H, Durbin R (2010) Fast and accurate long-read alignment with burrows-wheeler transform. Bioinformatics 26(5):589\u2013595","journal-title":"Bioinformatics"},{"issue":"12","key":"843_CR19","doi-asserted-by":"publisher","first-page":"e29393","DOI":"10.1371\/journal.pone.0029393","volume":"6","author":"KP Lin","year":"2011","unstructured":"Lin KP et al (2011) The mutational spectrum in a cohort of Charcot-Marie-tooth disease type 2 among the Han Chinese in Taiwan. PLoS One 6(12):e29393","journal-title":"PLoS One"},{"issue":"12","key":"843_CR20","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/jamaneurol.2016.2229","volume":"73","author":"DS Lynch","year":"2016","unstructured":"Lynch DS et al (2016) Analysis of mutations in AARS2 in a series of CSF1R-negative patients with adult-onset Leukoencephalopathy with axonal spheroids and pigmented glia. JAMA Neurol 73(12):1433\u20131439","journal-title":"JAMA Neurol"},{"issue":"5","key":"843_CR21","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1093\/brain\/awx045","volume":"140","author":"DS Lynch","year":"2017","unstructured":"Lynch DS et al (2017) Clinical and genetic characterization of leukoencephalopathies in adults. Brain 140(5):1204\u20131211","journal-title":"Brain"},{"issue":"9","key":"843_CR22","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","volume":"20","author":"A McKenna","year":"2010","unstructured":"McKenna A et al (2010) The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res 20(9):1297\u20131303","journal-title":"Genome Res"},{"issue":"1","key":"843_CR23","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1002\/humu.21635","volume":"33","author":"HM McLaughlin","year":"2012","unstructured":"McLaughlin HM et al (2012) A recurrent loss-of-function alanyl-tRNA synthetase (AARS) mutation in patients with Charcot-Marie-tooth disease type 2N (CMT2N). Hum Mutat 33(1):244\u2013253","journal-title":"Hum Mutat"},{"issue":"20","key":"843_CR24","doi-asserted-by":"publisher","first-page":"2040","DOI":"10.1212\/WNL.0000000000001583","volume":"84","author":"WW Motley","year":"2015","unstructured":"Motley WW et al (2015) A novel AARS mutation in a family with dominant myeloneuropathy. Neurology 84(20):2040\u20132047","journal-title":"Neurology"},{"issue":"10","key":"843_CR25","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.1002\/humu.23250","volume":"38","author":"T Nakayama","year":"2017","unstructured":"Nakayama T et al (2017) Deficient activity of alanyl-tRNA synthetase underlies an autosomal recessive syndrome of progressive microcephaly, hypomyelination, and epileptic encephalopathy. Hum Mutat 38(10):1348\u20131354","journal-title":"Hum Mutat"},{"issue":"3","key":"843_CR26","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/BF00691956","volume":"40","author":"J Peiffer","year":"1977","unstructured":"Peiffer J et al (1977) Generalized giant axonal neuropathy: a filament-forming disease of neuronal, endothelial, glial, and schwann cells in a patient without kinky hair. Acta Neuropathol 40(3):213\u2013218","journal-title":"Acta Neuropathol"},{"issue":"2","key":"843_CR27","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1038\/ng.1027","volume":"44","author":"R Rademakers","year":"2011","unstructured":"Rademakers R et al (2011) Mutations in the colony stimulating factor 1 receptor (CSF1R) gene cause hereditary diffuse leukoencephalopathy with spheroids. Nat Genet 44(2):200\u2013205","journal-title":"Nat Genet"},{"issue":"5","key":"843_CR28","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1002\/ana.410410515","volume":"41","author":"R Schiffmann","year":"1997","unstructured":"Schiffmann R et al (1997) Leukodystrophy in patients with ovarian dysgenesis. Ann Neurol 41(5):654\u2013661","journal-title":"Ann Neurol"},{"issue":"4","key":"843_CR29","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nmeth.2890","volume":"11","author":"JM Schwarz","year":"2014","unstructured":"Schwarz JM et al (2014) MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 11(4):361\u2013362","journal-title":"Nat Methods"},{"issue":"Web Server issu","key":"843_CR30","doi-asserted-by":"publisher","first-page":"W452","DOI":"10.1093\/nar\/gks539","volume":"40","author":"NL Sim","year":"2012","unstructured":"Sim NL et al (2012) SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res 40(Web Server issue):W452\u2013W457","journal-title":"Nucleic Acids Res"},{"issue":"4","key":"843_CR31","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.ajhg.2015.02.012","volume":"96","author":"C Simons","year":"2015","unstructured":"Simons C et al (2015) Loss-of-function alanyl-tRNA synthetase mutations cause an autosomal-recessive early-onset epileptic encephalopathy with persistent myelination defect. Am J Hum Genet 96(4):675\u2013681","journal-title":"Am J Hum Genet"},{"issue":"12","key":"843_CR32","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1038\/nprot.2015.124","volume":"10","author":"D Smedley","year":"2015","unstructured":"Smedley D et al (2015) Next-generation diagnostics and disease-gene discovery with the exomiser. Nat Protoc 10(12):2004\u20132015","journal-title":"Nat Protoc"},{"issue":"1","key":"843_CR33","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1111\/j.1600-0404.2011.01624.x","volume":"126","author":"C Sundal","year":"2012","unstructured":"Sundal C et al (2012) Update of the original HDLS kindred: divergent clinical courses. Acta Neurol Scand 126(1):67\u201375","journal-title":"Acta Neurol Scand"},{"issue":"1\u20132","key":"843_CR34","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jns.2011.10.006","volume":"314","author":"C Sundal","year":"2012","unstructured":"Sundal C et al (2012) Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): a misdiagnosed disease entity. J Neurol Sci 314(1\u20132):130\u2013137","journal-title":"J Neurol Sci"},{"issue":"10","key":"843_CR35","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/j.parkreldis.2013.05.013","volume":"19","author":"C Sundal","year":"2013","unstructured":"Sundal C et al (2013) Parkinsonian features in hereditary diffuse leukoencephalopathy with spheroids (HDLS) and CSF1R mutations. Parkinsonism Relat Disord 19(10):869\u2013877","journal-title":"Parkinsonism Relat Disord"},{"issue":"5","key":"843_CR36","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/jon.12037","volume":"24","author":"C Sundal","year":"2014","unstructured":"Sundal C et al (2014) Different stages of white matter changes in the original HDLS family revealed by advanced MRI techniques. J Neuroimaging 24(5):444\u2013452","journal-title":"J Neuroimaging"},{"key":"843_CR37","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/j.neures.2018.09.016","volume":"139","author":"Y Tatsumi","year":"2019","unstructured":"Tatsumi Y et al (2019) CMT type 2N disease-associated AARS mutant inhibits neurite growth that can be reversed by valproic acid. Neurosci Res 139:69\u201378","journal-title":"Neurosci Res"},{"key":"843_CR38","first-page":"21","volume":"65","author":"L Van Bogaert","year":"1936","unstructured":"Van Bogaert L, Nyssen R (1936) Le type tardif de la leukodystrophie progressive familiale. Rev Neurol 65:21\u201345","journal-title":"Rev Neurol"},{"issue":"2","key":"843_CR39","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1212\/WNL.54.2.463","volume":"54","author":"MS van der Knaap","year":"2000","unstructured":"van der Knaap MS et al (2000) Autosomal dominant diffuse leukoencephalopathy with neuroaxonal spheroids. Neurology 54(2):463\u2013468","journal-title":"Neurology"},{"issue":"4","key":"843_CR40","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1007\/s00401-016-1645-y","volume":"133","author":"J Weis","year":"2017","unstructured":"Weis J et al (2017) Towards a functional pathology of hereditary neuropathies. Acta Neuropathol 133(4):493\u2013515","journal-title":"Acta Neuropathol"},{"issue":"23","key":"843_CR41","first-page":"4036","volume":"27","author":"MAJ Weterman","year":"2018","unstructured":"Weterman MAJ et al (2018) Hypermorphic and hypomorphic AARS alleles in patients with CMT2N expand clinical and molecular heterogeneities. Hum Mol Genet 27(23):4036\u20134050","journal-title":"Hum Mol Genet"},{"issue":"21","key":"843_CR42","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1212\/WNL.0b013e3182574f8f","volume":"78","author":"Z Zhao","year":"2012","unstructured":"Zhao Z et al (2012) Alanyl-tRNA synthetase mutation in a family with dominant distal hereditary motor neuropathy. Neurology 78(21):1644\u20131649","journal-title":"Neurology"}],"container-title":["Acta Neuropathologica Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0843-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40478-019-0843-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40478-019-0843-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,11,26]],"date-time":"2020-11-26T00:38:55Z","timestamp":1606351135000},"score":1,"resource":{"primary":{"URL":"https:\/\/actaneurocomms.biomedcentral.com\/articles\/10.1186\/s40478-019-0843-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,27]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["843"],"URL":"https:\/\/doi.org\/10.1186\/s40478-019-0843-y","relation":{},"ISSN":["2051-5960"],"issn-type":[{"value":"2051-5960","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,27]]},"assertion":[{"value":"5 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Informed consent was obtained from all individual participants or their relatives. This study was approved by the Research Ethics Committee of Gothenburg (601-05, 1016-12).","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"This manuscript does not contain any identifiable personal data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"188"}}